R1 added Phare Denials to Phare OS as a generally available module for technical and clinical denials. It manages the denial lifecycle from early identification and evidence gathering through appeal creation and submission, with Phare Intelligence drafting appeals from clinical facts, payer policy and contract language. The same release lists Phare Auth, Phare Audit and Phare UM as generally available, with Phare CDI and Phare Recovery in early access only.
Our readHealth systems can now cover postbill denials and appeals on the same data foundation and payer playbook as their prebill modules, so denial patterns can feed back into authorization and audit work. Buyers should note R1 says clinician oversight remains essential for complex clinical denials but does not describe a required review step before appeals are submitted.